Zentalis Pharmaceuticals, Inc. (ZNTL) Dividend History
Income profile from 2018 to 2025 with payout safety and yield-on-cost trend
ZNTL Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
ZNTL Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
ZNTL Dividend History
No dividend payment history available
Get ZNTL's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
Zentalis Pharmaceuticals, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 1/9 — weak financial health.
Growth Track Record
ZNTL does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, ZNTL returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -93.7%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $1,517 today.
ZNTL Annual Dividend History (2018–2025)
8 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-1.91 | — | — | — |
| 2024 | $0.00 | — | 0 | $-2.33 | — | — | — |
| 2023 | $0.00 | — | 0 | $-4.47 | — | — | — |
| 2022 | $0.00 | — | 0 | $-4.48 | — | — | — |
| 2021 | $0.00 | — | 0 | $-3.72 | — | — | — |
| 2020 | $0.00 | — | 0 | $-2.87 | — | — | — |
| 2019 | $0.00 | — | 0 | $-1.29 | — | — | — |
| 2018 | $0.00 | — | 0 | $-1.17 | — | — | — |
What if you invested $1,000 in ZNTL back in 2018?
Total return with dividends reinvested · 8+ years of data
Calculate ReturnsHow much would $100/month in ZNTL be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs ZNTL Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationZNTL vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowZNTL — Frequently Asked Questions
Quick answers to the most common questions about buying ZNTL stock.
How much dividend does ZNTL pay per share?
Zentalis Pharmaceuticals, Inc. (ZNTL) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is ZNTL's next ex-dividend date?
ZNTL's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. ZNTL typically pays dividends quarterly.
Is ZNTL's dividend safe?
ZNTL's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has ZNTL increased its dividend?
ZNTL has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does ZNTL pay dividends?
Zentalis Pharmaceuticals, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 7+ years from 2018 to 2025.
How much would $10,000 invested in ZNTL grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in ZNTL five years ago would be worth approximately $627 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is ZNTL's yield on cost for long-term holders?
ZNTL's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.